Korea Asset Investment Securities (190650) 2026 outlook: a small KOSDAQ broker leaning on proprietary trading and investment banking, why it trades near 0.4x book, what a venture recovery could unlock, and Korean tax angles for foreign investors.
PIPR (Piper Sandler) stock outlook for 2026. A qualitative deep dive into how M&A advisory fees drive the cycle, why municipal finance and brokerage act as ballast, the acquire-and-recruit growth engine, and where the firm sits between bulge brackets and elite boutiques like Evercore and Moelis.
NMR (Nomura Holdings ADR) stock outlook for 2026. How Japan's largest brokerage earns money across retail, asset management and wholesale, what rate normalization and the new NISA mean for it, plus risks, dividends and US tax angles.
Moelis & Company (MC) 2026 stock outlook: the independent advisory boutique model, M&A and restructuring counter-cyclicality, partner-driven talent economics, compensation ratio, variable dividend risk, and how MC compares with Evercore, Lazard, PJT and Houlihan Lokey.
LS Securities (078020) stock outlook 2026: the bond-and-IB revenue model inherited from eBEST Investment Securities, the LS Group rebrand, mark-to-market bond gains, small-broker peer comparison, and Korean domestic stock tax rules explained for foreign investors.
DB Securities (016610, formerly DB Financial Investment) stock outlook 2026: how this mid-tier Korean broker built its edge in bond trading and structured-finance IB, why retail brokerage remains a weak spot, how real estate project-financing exposure shapes the risk case, and a peer comparison table for international investors.
TCBI (Texas Capital Bancshares) 2026 stock outlook. A deep qualitative look at a fast-growing Texas commercial bank rebuilding itself into a full-service investment bank, its net interest margin and deposit base, fee-income buildout, credit and concentration risk, and how it stacks up against Texas regional bank peers.
PJT Partners (PJT) 2026 stock outlook. A qualitative deep dive into the pure advisory boutique model, counter-cyclical restructuring revenue, Park Hill fund placement, the M&A recovery leverage, peer comparison with Moelis, Evercore and Lazard, plus key-person and deal-cycle risk.
Jefferies (JEF) 2026 stock analysis: the largest non-bulge-bracket investment bank's share-gain story, its advisory, underwriting and trading mix, the managing-director hiring flywheel moat, the post-Leucadia pure-play simplification, and the risks of IB cyclicality, comp ratio, and trading losses.
Evercore (EVR) 2026 stock analysis: the advisory-first investment bank's brand moat, managing-director hiring flywheel, restructuring counter-cyclicality, capital-light high-ROE model, and the risks of deal-cycle volatility, comp-ratio pressure, and talent war.
Houlihan Lokey (HLI) 2026 stock analysis: how the world's #1 restructuring franchise, mid-market M&A advisory, and valuation services hedge the business cycle, the capital-light high-ROE model, deal-volume and banker-talent risks, and how HLI compares to Evercore, Moelis, Lazard, and PJT.
Raymond James Financial (RJF) 2026 stock analysis: the independent advisor moat, net interest income exposure to falling rates, cash sorting risk, advisor recruiting economics, the TriState Capital deal, and how RJF stacks up against LPL and Schwab.
A 2026 stock outlook for NH Investment & Securities (KRX 005940), analyzing the NongHyup-affiliated broker's IB franchise (ECM, DCM, real estate), high-dividend policy, WM and retail brokerage, bond and trading P&L, real-estate PF exposure risk, the rate cycle, and the Korean value-up re-rating thesis.